NCT00164775View on ClinicalTrials.gov

The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia

PHASE3CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Functional Gastrointestinal Disorder
Interventions
DRUG

Imipramine

25mg nocte for first 2 weeks then 50 mg nocte for 10 weeks

DRUG

Placebo

One tab nocte for first 2 weeks then 2 tabs for 10 weeks

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00164775 - The Efficacy of Imipramine in Treatment of Refractory Functional Dyspepsia | Biotech Hunter | Biotech Hunter